Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes. Breiner A, Tapia CB, Lovblom LE, Perkins BA, Katzberg HD, Bril V. Neurol Neuroimmunol Neuroinflamm 2019 (Epub ahead of print). Abstract Objective: To determine whether IV immunoglobulin (IVIg) is more effective than placebo at reducing disability in patients with diabetes and demyelinating polyneuropathy features. […]

via Is IVIg effective in CIDP associated with diabetes? — Neurochecklists Blog

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s